CD274 and colorectal carcinoma: Notably, within the landscape of immune-based personalized therapies, immune cell PD-L1 expression is significantly higher in mismatch repair (MMR)-deficient (MSI-H) CRC compared to MMR-proficient (MSI-L) tumors, with no differences observed among distinct MSI-H molecular subtypes.